Medications

Drug design at the atomic level to thwart COVID-19

Although COVID-19 has faded from the headlines, SARS-CoV-2—the coronavirus behind the pandemic—is still rampantly infecting people around the world. Public health officials fear as the virus continues to evolve, it will ...

Medications

Who benefits from direct-to-consumer pharmaceutical advertising?

A new study co-authored by a University of Massachusetts Amherst economist reveals the value of government vaccine recommendations to drugmakers, as well as potential benefits of advertising pharmaceuticals directly to consumers—a ...

page 4 from 7